BIP
PDLI

Brandes Investment Partners’s PDL BioPharma, Inc. PDLI Stock Holding History

Brandes Investment Partners’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,723,376
Closed -$14.9M – 161
2020
Q3 		$14.9M Sell
4,723,376
-627,756
-12% -$2.01M 0.51% 56
2020
Q2 		$15.6M Sell
5,351,132
-382,440
-7% -$1.21M 0.47% 59
2020
Q1 		$16.2M Sell
5,733,572
-77,508
-1% -$250K 0.57% 56
2019
Q4 		$18.9M Buy
5,811,080
+345,924
+6% +$1M 0.45% 60
2019
Q3 		$11.8M Buy
5,465,156
+1,293,185
+31% +$3.46M 0.31% 69
2019
Q2 		$13.1M Sell
4,171,971
-173,112
-4% -$562K 0.29% 70
2019
Q1 		$16.2M Sell
4,345,083
-118,020
-3% -$398K 0.38% 63
2018
Q4 		$12.9M Buy
4,463,103
+526,384
+13% +$1.45M 0.33% 66
2018
Q3 		$10.4M Buy
3,936,719
+3,663,908
+1,343% +$8.99M 0.23% 65
2018
Q2 		$638K Sell
272,811
-547,930
-67% -$1.53M 0.01% 117
2018
Q1 		$2.41M Sell
820,741
-279,777
-25% -$764K 0.05% 104
2017
Q4 		$3.02M Sell
1,100,518
-12,161
-1% -$37.4K 0.06% 113
2017
Q3 		$3.77M Buy
1,112,679
+5,369
+0.5% +$14.9K 0.08% 104
2017
Q2 		$2.88M Buy
1,107,310
+1,048,732
+1,790% +$2.41M 0.05% 104
2017
Q1 		$133K Buy
+58,578
New +$130K ﹤0.01% 160

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Brandes Investment Partners's PDLI Position: Q4 2020 in Review

Brandes Investment Partners sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 4,723,376 shares — an estimated $14.9M sold.

Brandes Investment Partners first reported a position in PDLI in Q1 2017 and held it in 15 quarters. The position peaked at $18.9M in Q4 2019. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Brandes Investment Partners reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Brandes Investment Partners sold 4,723,376 PDL BioPharma, Inc. shares in Q4 2020, an estimated $14.9M.
  • Brandes Investment Partners first reported a position in PDL BioPharma, Inc. in Q1 2017 and held it in 15 quarters.
  • Brandes Investment Partners's PDL BioPharma, Inc. position peaked at $18.9M in Q4 2019.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Brandes Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.